Zelalem Eshete

Array ( [id] => 8241180 [patent_doc_number] => 20120149898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES' [patent_app_type] => utility [patent_app_number] => 13/206638 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53497 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13206638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774837 [patent_doc_number] => 08119797 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Production method' [patent_app_type] => utility [patent_app_number] => 13/204969 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5048 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119797.pdf [firstpage_image] =>[orig_patent_app_number] => 13204969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8104295 [patent_doc_number] => 08153800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Macrocyclic inhibitors of hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 13/197226 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40175 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153800.pdf [firstpage_image] =>[orig_patent_app_number] => 13197226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808028 [patent_doc_number] => 20120058982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 13/191761 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 38686 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058982.pdf [firstpage_image] =>[orig_patent_app_number] => 13191761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586357 [patent_doc_number] => 20110280867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/191978 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11932 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280867.pdf [firstpage_image] =>[orig_patent_app_number] => 13191978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560247 [patent_doc_number] => 08334311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Indoline anti-cancer agents' [patent_app_type] => utility [patent_app_number] => 13/190324 [patent_app_country] => US [patent_app_date] => 2011-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28683 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13190324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587543 [patent_doc_number] => 20110282053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 13/188795 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6165 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20110282053.pdf [firstpage_image] =>[orig_patent_app_number] => 13188795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056133 [patent_doc_number] => 20120077805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'UNSOLVATED BENZODIAZEPINE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/188234 [patent_app_country] => US [patent_app_date] => 2011-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 39369 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077805.pdf [firstpage_image] =>[orig_patent_app_number] => 13188234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9041659 [patent_doc_number] => 20130244297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'PROCESS FOR THE PREPARATION OF (3R, 3AS, 6AR)-HEXAHYDROFURO [2, 3- B] FURAN-3-OL' [patent_app_type] => utility [patent_app_number] => 13/989166 [patent_app_country] => US [patent_app_date] => 2011-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5436 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875345 [patent_doc_number] => 08962613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'P2X4 receptor antagonist' [patent_app_type] => utility [patent_app_number] => 13/807387 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17388 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555240 [patent_doc_number] => 08329712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Heterocyclic antiviral compounds' [patent_app_type] => utility [patent_app_number] => 13/177220 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18406 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977608 [patent_doc_number] => 20130211038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'HIGH TEMPERATURE LACTAM NEUTRALISATION' [patent_app_type] => utility [patent_app_number] => 13/807995 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7840 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13807995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642832 [patent_doc_number] => 08367819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Synthesis of caprolactam from lysine' [patent_app_type] => utility [patent_app_number] => 13/175450 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5772 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13175450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8398621 [patent_doc_number] => 08268992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-18 [patent_title] => 'Thiolactams and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/173161 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38895 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13173161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7710204 [patent_doc_number] => 20120003215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/167618 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 107967 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13167618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063557 [patent_doc_number] => 20110245238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof' [patent_app_type] => utility [patent_app_number] => 13/162731 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24453 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245238.pdf [firstpage_image] =>[orig_patent_app_number] => 13162731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8756043 [patent_doc_number] => 20130090348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-11 [patent_title] => 'POLYMORPHIC FORMS OF RIFAXIMIN' [patent_app_type] => utility [patent_app_number] => 13/704938 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3799 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628681 [patent_doc_number] => 09346826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Process for producing an intermediate for a cyclic carbodiimide compound' [patent_app_type] => utility [patent_app_number] => 13/704093 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3102 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745557 [patent_doc_number] => 20130085274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'PROCESS FOR THE PRODUCTION OF A CARBODIIMIDE' [patent_app_type] => utility [patent_app_number] => 13/704117 [patent_app_country] => US [patent_app_date] => 2011-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7119 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577748 [patent_doc_number] => 08343958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => '3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/154144 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66376 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13154144 [rel_patent_id] =>[rel_patent_doc_number] =>)